Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer
Recruiting · NCT05950503 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
View the official record on ClinicalTrials.gov →Interventions studied
Hepatic MRI
What this trial is about
This study wants to evaluate the use of MRI in the managemente of mCRC with liver only metastases.
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age \> 18 years;
- Histological diagnosis of colorectal cancer;
- Presence of liver metastases in the staging exams (chest-abdomen CT with contrast medium or PET-CT with 18-FDG);
- At least one measurable liver lesion according to RECIST 1.1 criteria;
- Adequate organ and marrow function.
Exclusion criteria
- Age \< 18 years;
- Inability to undergo MRI;
- Major contraindications to liver surgery;
- No written informed consent.
Where it is running
1 location listed.
- Policlinico Agostino Gemelli - Roma, Italy